Dong-A Pharmaceutical Co.,Ltd. (KRX:000640)

Dong-A Pharmaceutical Revenue

Dong-A Pharmaceutical had revenue of 412.39B KRW in the quarter ending June 30, 2026, with 18.88% growth. This brings the company's total for the last twelve months to 1.52T, up 10.06% year-over-year. In the year 2025, Dong-A Pharmaceutical had annual revenue of 1.43T with 7.24% growth. That makes Dong-A Pharmaceutical the 7,032nd largest company in the world by revenue and 313th in South Korea.

• Revenue (ttm): 1.52T
• Revenue Growth: +10.06%
• P/S Ratio: 0.39
• Revenue / Employee: 19.21B
• Employees: 79
• Market Cap: 592.23B

Revenue Chart

Chart

Chart

Revenue by Segment

By Segment

Chart

• Over-The-Counter Drugs and Quasi-Drugs 726.28B 43.7%
• Logistics 423.83B 25.5%
• Other 165.79B 10.0%
• Packaging Containers / Raw Water 160.45B 9.7%
• Biosimilars and Contract Medicines 103.73B 6.2%
• Holding Company 81.23B 4.9%

By Geography

Chart

• South Korea 1.41T 98.4%
• Japan 10.74B 0.8%
• China 9.20B 0.6%
• Other 3.64B 0.3%

Fiscal year ended Dec 31, 2025 See the full Dong-A Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.43T	96.54B	7.24%
Dec 31, 2024	1.33T	201.23B	17.78%
Dec 31, 2023	1.13T	117.14B	11.54%
Dec 31, 2022	1.01T	132.92B	15.07%
Dec 31, 2021	881.94B	98.63B	12.59%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error